Seven years ago, Theranos was a $9 billion dynamo seemingly on the precipice of blowing the blood testing market wide open. Today, the company and its CEO and founder, Elizabeth Holmes, are a beleaguered group surrounded by legal adversaries and struggling to survive. Recent months have seen the firm retrench and seek to settle its…
Theranos & Its CEO Settle Stock Fraud Charges with SEC
Seven years ago, Theranos was a $9 billion dynamo seemingly on the precipice of blowing the blood testing market wide open. Today, the company and its CEO and founder, Elizabeth Holmes, are a beleaguered group surrounded by legal adversaries and struggling to survive. Recent months have seen the firm retrench and seek to settle its […]